Click for best price
Endometrial Cancer Therapeutics Market Size, Share 2022
This report contains market size and forecasts of Endometrial Cancer Therapeutics in Global, including the following market information:
Global Endometrial Cancer Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Endometrial Cancer Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Chemotherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Endometrial Cancer Therapeutics include Bayer AG, F. Hoffman La Roche Ltd., Bristol-Myers Squibb Company, Merck KGaA, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Sanofi and GlaxoSmithKline plc and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Endometrial Cancer Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Endometrial Cancer Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Therapeutics Market Segment Percentages, by Type, 2021 (%)
Chemotherapy
Hormone Therapy
Radiation Therapy
Surgery
Global Endometrial Cancer Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Endometrial Cancer Therapeutics Market Segment Percentages, by Application, 2021 (%)
Research Institutes
Hospitals & Clinics
Global Endometrial Cancer Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Endometrial Cancer Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Endometrial Cancer Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Endometrial Cancer Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
F. Hoffman La Roche Ltd.
Bristol-Myers Squibb Company
Merck KGaA
Novartis AG
Takeda Pharmaceutical Company Limited
Eli Lilly and Company
Sanofi
GlaxoSmithKline plc
ArQule, Inc.
| Report Attributes |
Report Details |
| Report Title |
Endometrial Cancer Therapeutics Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Endometrial Cancer Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Endometrial Cancer Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Endometrial Cancer Therapeutics Overall Market Size
2.1 Global Endometrial Cancer Therapeutics Market Size: 2021 VS 2028
2.2 Global Endometrial Cancer Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Endometrial Cancer Therapeutics Players in Global Market
3.2 Top Global Endometrial Cancer Therapeutics Companies Ranked by Revenue
3.3 Global Endometrial Cancer Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Endometrial Cancer Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Endometrial Cancer Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Endometrial Cancer Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Endometrial Cancer Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Endometrial Cancer Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Endometrial Cancer Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Chemotherapy
4.1.3 Hormone Therapy
4.1.4 Radiation Therapy
4.1.5 Surgery
4.2 By Type - Global Endometrial Cancer Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Endometrial Cancer Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Endometrial Cancer Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Endometrial Cancer Therapeutics Market Size, 2021 & 2028
5.1.2 Research Institutes
5.1.3 Hospitals & Clinics
5.2 By Application - Global Endometrial Cancer Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Endometrial Cancer Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Endometrial Cancer Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Endometrial Cancer Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Endometrial Cancer Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Endometrial Cancer Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Endometrial Cancer Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Endometrial Cancer Therapeutics Revenue, 2017-2028
6.3.2 US Endometrial Cancer Therapeutics Market Size, 2017-2028
6.3.3 Canada Endometrial Cancer Therapeutics Market Size, 2017-2028
6.3.4 Mexico Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Endometrial Cancer Therapeutics Revenue, 2017-2028
6.4.2 Germany Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.3 France Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.4 U.K. Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.5 Italy Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.6 Russia Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Endometrial Cancer Therapeutics Market Size, 2017-2028
6.4.8 Benelux Endometrial Cancer Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Endometrial Cancer Therapeutics Revenue, 2017-2028
6.5.2 China Endometrial Cancer Therapeutics Market Size, 2017-2028
6.5.3 Japan Endometrial Cancer Therapeutics Market Size, 2017-2028
6.5.4 South Korea Endometrial Cancer Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Endometrial Cancer Therapeutics Market Size, 2017-2028
6.5.6 India Endometrial Cancer Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Endometrial Cancer Therapeutics Revenue, 2017-2028
6.6.2 Brazil Endometrial Cancer Therapeutics Market Size, 2017-2028
6.6.3 Argentina Endometrial Cancer Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Endometrial Cancer Therapeutics Revenue, 2017-2028
6.7.2 Turkey Endometrial Cancer Therapeutics Market Size, 2017-2028
6.7.3 Israel Endometrial Cancer Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Endometrial Cancer Therapeutics Market Size, 2017-2028
6.7.5 UAE Endometrial Cancer Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Bayer AG
7.1.1 Bayer AG Corporate Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Endometrial Cancer Therapeutics Major Product Offerings
7.1.4 Bayer AG Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Bayer AG Key News
7.2 F. Hoffman La Roche Ltd.
7.2.1 F. Hoffman La Roche Ltd. Corporate Summary
7.2.2 F. Hoffman La Roche Ltd. Business Overview
7.2.3 F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Major Product Offerings
7.2.4 F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.2.5 F. Hoffman La Roche Ltd. Key News
7.3 Bristol-Myers Squibb Company
7.3.1 Bristol-Myers Squibb Company Corporate Summary
7.3.2 Bristol-Myers Squibb Company Business Overview
7.3.3 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Major Product Offerings
7.3.4 Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Bristol-Myers Squibb Company Key News
7.4 Merck KGaA
7.4.1 Merck KGaA Corporate Summary
7.4.2 Merck KGaA Business Overview
7.4.3 Merck KGaA Endometrial Cancer Therapeutics Major Product Offerings
7.4.4 Merck KGaA Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Merck KGaA Key News
7.5 Novartis AG
7.5.1 Novartis AG Corporate Summary
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Endometrial Cancer Therapeutics Major Product Offerings
7.5.4 Novartis AG Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Novartis AG Key News
7.6 Takeda Pharmaceutical Company Limited
7.6.1 Takeda Pharmaceutical Company Limited Corporate Summary
7.6.2 Takeda Pharmaceutical Company Limited Business Overview
7.6.3 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Takeda Pharmaceutical Company Limited Key News
7.7 Eli Lilly and Company
7.7.1 Eli Lilly and Company Corporate Summary
7.7.2 Eli Lilly and Company Business Overview
7.7.3 Eli Lilly and Company Endometrial Cancer Therapeutics Major Product Offerings
7.7.4 Eli Lilly and Company Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Eli Lilly and Company Key News
7.8 Sanofi
7.8.1 Sanofi Corporate Summary
7.8.2 Sanofi Business Overview
7.8.3 Sanofi Endometrial Cancer Therapeutics Major Product Offerings
7.8.4 Sanofi Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Sanofi Key News
7.9 GlaxoSmithKline plc
7.9.1 GlaxoSmithKline plc Corporate Summary
7.9.2 GlaxoSmithKline plc Business Overview
7.9.3 GlaxoSmithKline plc Endometrial Cancer Therapeutics Major Product Offerings
7.9.4 GlaxoSmithKline plc Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.9.5 GlaxoSmithKline plc Key News
7.10 ArQule, Inc.
7.10.1 ArQule, Inc. Corporate Summary
7.10.2 ArQule, Inc. Business Overview
7.10.3 ArQule, Inc. Endometrial Cancer Therapeutics Major Product Offerings
7.10.4 ArQule, Inc. Endometrial Cancer Therapeutics Revenue in Global Market (2017-2022)
7.10.5 ArQule, Inc. Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Endometrial Cancer Therapeutics Market Opportunities & Trends in Global Market
Table 2. Endometrial Cancer Therapeutics Market Drivers in Global Market
Table 3. Endometrial Cancer Therapeutics Market Restraints in Global Market
Table 4. Key Players of Endometrial Cancer Therapeutics in Global Market
Table 5. Top Endometrial Cancer Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Endometrial Cancer Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Endometrial Cancer Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Endometrial Cancer Therapeutics Product Type
Table 9. List of Global Tier 1 Endometrial Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Endometrial Cancer Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Endometrial Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Endometrial Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Endometrial Cancer Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Endometrial Cancer Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Endometrial Cancer Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Endometrial Cancer Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Bayer AG Corporate Summary
Table 31. Bayer AG Endometrial Cancer Therapeutics Product Offerings
Table 32. Bayer AG Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. F. Hoffman La Roche Ltd. Corporate Summary
Table 34. F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Product Offerings
Table 35. F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Bristol-Myers Squibb Company Corporate Summary
Table 37. Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Product Offerings
Table 38. Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Merck KGaA Corporate Summary
Table 40. Merck KGaA Endometrial Cancer Therapeutics Product Offerings
Table 41. Merck KGaA Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Endometrial Cancer Therapeutics Product Offerings
Table 44. Novartis AG Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Takeda Pharmaceutical Company Limited Corporate Summary
Table 46. Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Product Offerings
Table 47. Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly and Company Corporate Summary
Table 49. Eli Lilly and Company Endometrial Cancer Therapeutics Product Offerings
Table 50. Eli Lilly and Company Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Sanofi Corporate Summary
Table 52. Sanofi Endometrial Cancer Therapeutics Product Offerings
Table 53. Sanofi Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. GlaxoSmithKline plc Corporate Summary
Table 55. GlaxoSmithKline plc Endometrial Cancer Therapeutics Product Offerings
Table 56. GlaxoSmithKline plc Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. ArQule, Inc. Corporate Summary
Table 58. ArQule, Inc. Endometrial Cancer Therapeutics Product Offerings
Table 59. ArQule, Inc. Endometrial Cancer Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Endometrial Cancer Therapeutics Segment by Type in 2021
Figure 2. Endometrial Cancer Therapeutics Segment by Application in 2021
Figure 3. Global Endometrial Cancer Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Endometrial Cancer Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Endometrial Cancer Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Endometrial Cancer Therapeutics Revenue in 2021
Figure 8. By Type - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Endometrial Cancer Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Endometrial Cancer Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer AG Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. F. Hoffman La Roche Ltd. Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Bristol-Myers Squibb Company Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Merck KGaA Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Takeda Pharmaceutical Company Limited Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly and Company Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Sanofi Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. GlaxoSmithKline plc Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. ArQule, Inc. Endometrial Cancer Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
